APGE - NASDAQ

Apogee Therapeutics, Inc.

APGE·NASDAQ

$84.19

+3.0%

HealthcareBiotechnology

Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs include APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. The company was founded in 2022 and is based in Waltham, Massachusetts.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$5.21B

EPS-4.2200

P/E Ratio-19.95

Earnings Date08/10/2026

apge

Selling, General and Administrative Expenses

Last Annual Value

70.88M

3-Year CAGR

189%

5-Year CAGR

89%

10-Year CAGR

37%

Adjust for Inflation

Apogee Therapeutics, Inc. Competitors Analysis of Selling, General and Administrative Expenses

APGE · NASDAQ

Company	Selling, General and Administrative Expenses	CAGR 3Y	CAGR 5Y	CAGR 10Y
Apogee Therapeutics, Inc. NASDAQ:APGE	70.88M	42.3%	N/A	N/A
Legend Biotech Corporation NASDAQ:LEGN	342.50M	19.5%	18.0%	N/A
Ultragenyx Pharmaceutical Inc. NASDAQ:RARE	349.00M	4.1%	9.7%	18.3%
CG Oncology, Inc. Common stock NASDAQ:CGON	73.53M	95.1%	73.8%	N/A
Celcuity Inc. NASDAQ:CELC	27.20M	69.0%	59.9%	59.0%
Disc Medicine, Inc. NASDAQ:IRON	65.38M	44.1%	62.5%	N/A
Soleno Therapeutics, Inc. NASDAQ:SLNO	132.13M	114.0%	65.0%	31.8%

Apogee Therapeutics, Inc. Fair Value Envelope

APGE · NASDAQ

Our analysis suggests that APGE has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $84.19, this represents a potential HIDDEN relative to our calculated worth for Apogee Therapeutics, Inc..

HIDDEN

Intrinsic Value

Current Price: $84.19

Related Guides

Blog Categories

Continue your APGE research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.